Table 2 HPV vaccine recommendation quality (n = 83)
Pre-training M (SD) | One-month follow-up M (SD) | |
|---|---|---|
Recommendation quality index | 4.9 (1.2) | 5.3 (0.7)* |
Recommendation quality items | ||
I start routinely recommending HPV vaccine when patients turn 11 or 12. (timeliness) | 4.3 (0.8) | 4.6 (0.5)* |
I recommend HPV vaccine more often for adolescents at higher risk for getting HPV. (consistency, reverse coded in quality index) | 3.0 (1.3) | 3.0 (1.3) |
When I recommend HPV vaccine, I say it is very important. (strength of endorsement) | 4.1 (0.8) | 4.4 (0.6)* |
When I recommend HPV vaccine, I recommend getting it that day. (urgency) | 4.2 (0.7) | 4.5 (0.6)* |
I promote HPV vaccination as part of routine adolescent care. (routine care) | 4.6 (0.6) | 4.7 (0.5)* |
When I recommend HPV vaccine, I emphasize that it can prevent cancer. (cancer prevention) | 4.7 (0.5) | 4.7 (0.5) |